• Search
  • Advanced Search

Review Article

April 19, 2021


Food Preferences and Obesity
Sara Spinelli, Erminio Monteleone
Endocrinol Metab. 2021;36(2):209-219.
Obesity is a multifactorial disease with several potential causes that remain incompletely understood. Recent changes in the environment, which has become increasingly obesogenic, have been found to interact with individual...

Review Article

March 24, 2021


Digital Therapeutics for Obesity and Eating-Related Problems
Meelim Kim, Hyung Jin Choi
Endocrinol Metab. 2021;36(2):220-228.

In recent years, digital technologies have rapidly advanced and are being applied to remedy medical problems. These technologies allow us to monitor and manage our physical and mental health in...

Review Article

April 6, 2021


Dopaminergic Control of the Feeding Circuit
Ja-Hyun Baik
Endocrinol Metab. 2021;36(2):229-239.

There is increasing evidence demonstrating that reward-related motivational food intake is closely connected with the brain’s homeostatic system of energy balance and that this interaction might be important in the...

Review Article

March 31, 2021


Continuous Glucose Monitoring in the Hospital
M. Citlalli Perez-Guzman, Trisha Shang, Jennifer Y. Zhang, et al.
Endocrinol Metab. 2021;36(2):240-255.

Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes...

Review Article

April 19, 2021


Cardiorenal Protection in Diabetic Kidney Disease
Jason F. Lee, Ecaterina Berzan, Vikas S. Sridhar, et al.
Endocrinol Metab. 2021;36(2):256-269.

Over the last 5 years there have been many new developments in the management of diabetic kidney disease. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 (SGLT2) inhibitors were...

Review Article

March 24, 2021


Operationalizing Treat-to-Target for Osteoporosis
E. Michael Lewiecki
Endocrinol Metab. 2021;36(2):270-278.

Treat-to-target (TTT) for osteoporosis is a concept for individualizing patient treatment decisions that focuses on achieving an acceptable level of fracture risk rather than response to treatment alone. While a...

Review Article

April 19, 2021


Role of PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia
Brian Tomlinson, Nivritti Gajanan Patil, Manson Fok, et al.
Endocrinol Metab. 2021;36(2):279-295.

Patients with familial hypercholesterolemia (FH) are at high or very high risk for cardiovascular disease. Those with heterozygous FH (HeFH) often do not reach low-density lipoprotein cholesterol (LDL-C) targets with...

Review Article

April 15, 2021


An Update on Contraception in Polycystic Ovary Syndrome
Seda Hanife Oguz, Bulent Okan Yildiz
Endocrinol Metab. 2021;36(2):296-311.

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in reproductive-aged women, characterized by hyperandrogenism, oligo/anovulation, and polycystic ovarian morphology. Combined oral contraceptives (COCs), along with lifestyle modifications, represent the...

Review Article

April 27, 2021


Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors
Shintaro Iwama, Tomoko Kobayashi, Hiroshi Arima
Endocrinol Metab. 2021;36(2):312-321.

Immune-related adverse events (irAEs) affecting the endocrine glands are among the most frequent irAEs induced by immune checkpoint inhibitors (ICIs) and include hypopituitarism, primary adrenal insufficiency, thyrotoxicosis, hypothyroidism, hypoparathyroidism, and...

Original Article

Clinical Study

March 23, 2021


Associations of GNAS Mutations with Surgical Outcomes in Patients with Growth Hormone-Secreting Pituitary Adenoma
Hyein Jung, Kyungwon Kim, Daham Kim, et al.
Endocrinol Metab. 2021;36(2):342-350.

Background: The guanine nucleotide-binding protein, alpha stimulating (GNAS) gene has been associated with growth hormone (GH)-secreting pituitary adenoma. We investigated the prevalence of GNAS mutations in Korean patients with acromegaly...

Original Article

Clinical Study

April 6, 2021


Radioactive Parathyroid Adenomas on Sestamibi Scans: Low Parathyroid Hormone Secretory Potential and Large Volume
Sung Hye Kong, Jung Hee Kim, Sang Wan Kim, et al.
Endocrinol Metab. 2021;36(2):351-358.

Background: We investigated the clinical characteristics of parathyroid adenomas according to radioactivity on 99mTc-methoxyisobutylisonitrile (99mTc-MIBI) single-photon emission computed tomography/computed tomography (SPECT/CT) in primary hyperparathyroidism (PHPT) patients. Methods: The study included 217...

Original Article

Clinical Study

March 23, 2021


Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in Papillary Thyroid Microcarcinoma
Min Ji Jeon, Yea Eun Kang, Jae Hoon Moon, et al.
Endocrinol Metab. 2021;36(2):359-364.

Background: A Korean Multicenter Prospective cohort study of Active Surveillance or Surgery (KoMPASS) for papillary thyroid microcarcinomas (PTMCs) has been initiated. The aim is to compare clinical outcomes between active...

Original Article

Clinical Study

April 7, 2021


Gender-Dependent Reference Range of Serum Calcitonin Levels in Healthy Korean Adults
Eyun Song, Min Ji Jeon, Hye Jin Yoo, et al.
Endocrinol Metab. 2021;36(2):365-373.

Background: Serum calcitonin measurement contains various clinical and methodological aspects. Its reference level is wide and unclear despite sensitive calcitonin kits are available. This study aimed to identify the specific...

Original Article

Clinical Study

April 6, 2021


Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis
Deep Dutta, Anshita Agarwal, Indira Maisnam, et al.
Endocrinol Metab. 2021;36(2):374-387.

Background: No meta-analysis has holistically analysed and summarised the efficacy and safety of gemigliptin in type 2 diabetes. The meta-analysis addresses this knowledge gap. Methods: Electronic databases were searched for randomised...

Original Article

Clinical Study

March 31, 2021


Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, et al.
Endocrinol Metab. 2021;36(2):388-400.

Background: To compare the renal effects of dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors on individual outcomes in patients with type 2 diabetes. Methods: We searched electronic databases...

Original Article

Clinical Study

March 31, 2021


Diagnostic Accuracy of Computed Tomography in Predicting Primary Aldosteronism Subtype According to Age
Seung Hun Lee, Jong Woo Kim, Hyun-Ki Yoon, et al.
Endocrinol Metab. 2021;36(2):401-412.

Background: Guidelines by the Endocrine Society Guideline on bypassing adrenal vein sampling (AVS) in patients

Original Article

Clinical Study

April 6, 2021


Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
Jee Hee Yoon, A Ram Hong, Hee Kyung Kim, et al.
Endocrinol Metab. 2021;36(2):413-423.

Background: Thyroid immune-related adverse events (IRAEs) have been reported in patients treated with programmed cell death protein-1 (PD-1) and programmed cell death protein-ligand 1 (PD-L1) inhibitors. We investigated the incidence...

Original Article

Clinical Study

April 14, 2021


Cumulative Exposure to Metabolic Syndrome Components and the Risk of Dementia: A Nationwide Population-Based Study
Yunjung Cho, Kyungdo Han, Da Hye Kim, et al.
Endocrinol Metab. 2021;36(2):424-435.

Background: Metabolic disturbances are modifiable risk factors for dementia. Because the status of metabolic syndrome (MetS) and its components changes over time, we aimed to investigate the association of the...

Original Article

Clinical Study

April 19, 2021


High Serum-Induced AhRL Is Associated with Prevalent Metabolic Syndrome and Future Impairment of Glucose Tolerance in the Elderly
Youngmi Kim Pak, Hoon Sung Choi, Wook Ha Park, et al.
Endocrinol Metab. 2021;36(2):436-446.

Background: High circulating levels of dioxins and dioxin-like chemicals, acting via the aryl hydrocarbon receptor (AhR), have previously been linked to diabetes. We now investigated whether the serum AhR ligands...

Original Article

Endocrine Research

March 31, 2021


DEHP Down-Regulates Tshr Gene Expression in Rat Thyroid Tissues and FRTL-5 Rat Thyrocytes: A Potential Mechanism of Thyroid Disruption
Min Joo Kim, Hwan Hee Kim, Young Shin Song, et al.
Endocrinol Metab. 2021;36(2):447-454.

Background: Di-2-ethylhexyl phthalate (DEHP) is known to disrupt thyroid hormonal status. However, the underlying molecular mechanism of this disruption is unclear. Therefore, we investigated the direct effects of DEHP on...

Original Article

Endocrine Research

April 14, 2021


Effect of CCL11 on In Vitro Myogenesis and Its Clinical Relevance for Sarcopenia in Older Adults
Da Ae Kim, So Jeong Park, Jin Young Lee, et al.
Endocrinol Metab. 2021;36(2):455-465.

Background: The C-C motif chemokine ligand 11 (CCL11) has been receiving attention as a potential pro-aging factor. Accordingly, it may be involved in muscle metabolism and sarcopenia, a key component...
Current Issue
Volume 36(2); Apr 2021
Long-Term Outcomes Following Thermal Ablation of Benign Thyroid Nodules as an Alternative to Surgery: The Importance of Controlling Regrowth
Jung Suk Sim, Jung Hwan Baek
Endocrinol Metab. 2019;34(2):117-123.

Review Article

Jun 24, 2019
Graves' Disease: Can It Be Cured?
Wilmar M. Wiersinga
Endocrinol Metab. 2019;34(1):29-38.

Review Article

Mar 21, 2019
Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
Eun-Jung Rhee
Endocrinol Metab. 2019;34(3):226-233.

Review Article

Sep 26, 2019
Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults
Sang Bae Lee, Min Kyung Kim, Shinae Kang, et al.
Endocrinol Metab. 2019;34(2):179-186.

Original Article

Clinical Study

May 20, 2019
Recent Progress on Branched-Chain Amino Acids in Obesity, Diabetes, and Beyond
Md Abu Bakkar Siddik, Andrew C. Shin
Endocrinol Metab. 2019;34(3):234-246.

Review Article

Sep 26, 2019
Genomic Characterization of Differentiated Thyroid Carcinoma
Young Shin Song, Young Joo Park
Endocrinol Metab. 2019;34(1):1-10.

Namgok Lecture 2018

Mar 21, 2019
Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Jae Hyun Bae, Sunhee Kim, Eun-Gee Park, et al.
Endocrinol Metab. 2019;34(1):80-92.

Original Article

Mar 21, 2019
Bisphenols and Thyroid Hormone
Min Joo Kim, Young Joo Park
Endocrinol Metab. 2019;34(4):340-348.

Review Article

Dec 23, 2019
Implications of Mitochondrial Unfolded Protein Response and Mitokines: A Perspective on Fatty Liver Diseases
Hyon-Seung Yi
Endocrinol Metab. 2019;34(1):39-46.

Review Article

Mar 21, 2019
Impact of Skeletal Muscle Mass on Metabolic Health
Gyuri Kim, Jae Hyeon Kim
Endocrinol Metab. 2020;35(1):1-6.

Namgok Lecture 2019

Mar 19, 2020
Prevalence and Current Management of Cardiovascular Risk Factors in Korean Adults Based on Fact Sheets
Eun-Jung Rhee
Endocrinol Metab. 2020;35(1):85-94.

Review Article

Mar 19, 2020
Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
Jierui Liu, Yanqing Liu, Yansong Lin, et al.
Endocrinol Metab. 2019;34(3):215-225.

Review Article

Sep 26, 2019
Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer
Myung-Chul Lee, Min Joo Kim, Hoon Sung Choi, et al.
Endocrinol Metab. 2019;34(2):150-157.

Original Article

Clinical Study

May 10, 2019
Medical Big Data Is Not Yet Available: Why We Need Realism Rather than Exaggeration
Hun-Sung Kim, Dai-Jin Kim, Kun-Ho Yoon
Endocrinol Metab. 2019;34(4):349-354.

Review Article

Dec 23, 2019
A Review of the Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors on Lean Body Mass in Humans
Jack Alistair Sargeant, Joseph Henson, James Adam King, et al.
Endocrinol Metab. 2019;34(3):247-262.

Review Article

Sep 26, 2019
Encountering COVID-19 as Endocrinologists
Eun-Jung Rhee, Jung Hee Kim, Sun Joon Moon, et al.
Endocrinol Metab. 2020;35(2):197-205.

Review Article

Jun 23, 2020
Association between Circulating Irisin and C-Reactive Protein Levels: A Systematic Review and Meta-Analysis
Elham Eslampour, Farzad Ebrahimzadeh, Amir Abbasnezhad, et al.
Endocrinol Metab. 2019;34(2):140-149.

Original Article

Clinical Study

Jun 24, 2019
Impact of the Dynamic Change of Metabolic Health Status on the Incident Type 2 Diabetes: A Nationwide Population-Based Cohort Study
Jung A Kim, Da Hye Kim, Seon Mee Kim, et al.
Endocrinol Metab. 2019;34(4):406-414.

Original Article

Clinical Study

Dec 23, 2019
The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes
Gwang Sil Kim, Joong Hyun Park, Jong Chul Won
Endocrinol Metab. 2019;34(2):106-116.

Review Article

May 9, 2019
Natural Killer Cells and Thyroid Diseases
Eun Kyung Lee, John B. Sunwoo
Endocrinol Metab. 2019;34(2):132-137.

Review Article

Jun 24, 2019
Fasting Plasma Glucose Level Independently Predicts the Mortality of Patients with Coronavirus Disease 2019 Infection: A Multicenter, Retrospective Cohort Study
Min Cheol Chang, Jong-Moon Hwang, Jae-Han Jeon, et al.
Endocrinol Metab. 2020;35(3):595-601.

Original Article

Clinical Study

Aug 26, 2020
Long-Term Results of Thermal Ablation of Benign Thyroid Nodules: A Systematic Review and Meta-Analysis
Se Jin Cho, Jung Hwan Baek, Sae Rom Chung, et al.
Endocrinol Metab. 2020;35(2):339-350.

Original Article

Clinical Study

Jun 24, 2020
Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
Chan-Hee Jung, Eun-Jung Rhee, Hyemi Kwon, et al.
Endocrinol Metab. 2020;35(1):165-176.

Original Article

Clinical Study

Mar 19, 2020
Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data
Ji Hong You, Sun Ok Song, Se Hee Park, et al.
Endocrinol Metab. 2019;34(3):275-281.

Original Article

Clinical Study

Sep 26, 2019
Serotonin Regulates De Novo Lipogenesis in Adipose Tissues through Serotonin Receptor 2A
Ko Eun Shong, Chang-Myung Oh, Jun Namkung, et al.
Endocrinol Metab. 2020;35(2):470-479.Correction in: Endocrinol Metab 2020;35(3):672

Original Article

Endocrine Research

Jun 24, 2020
Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
Won Bae Kim, Min Ji Jeon, Won Gu Kim, et al.
Endocrinol Metab. 2020;35(1):14-25.

Review Article

Mar 19, 2020
Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
Jung Hee Kim, Hyemi Moon, Junghyun Noh, et al.
Endocrinol Metab. 2020;35(1):157-164.

Original Article

Clinical Study

Mar 19, 2020
Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, et al.
Endocrinol Metab. 2019;34(3):268-274.

Original Article

Clinical Study

Sep 26, 2019
Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea
Da Hea Seo, Shinae Kang, Yong-ho Lee, et al.
Endocrinol Metab. 2019;34(3):282-290.

Original Article

Clinical Study

Sep 26, 2019
Transcriptome Analysis Identifies an Attenuated Local Immune Response in Invasive Nonfunctioning Pituitary Adenomas
Yong Hwy Kim, Jung Hee Kim
Endocrinol Metab. 2019;34(3):314-322.Correction in: Endocrinol Metab 2020;35(4):965

Original Article

Endocrine Research

Sep 26, 2019

Endocrinology
and Metabolism

Print ISSN: 2093-596X
Online ISSN: 2093-5978

Editorial Office
101-2503, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-716-2428    Fax: +82-2-714-5103    E-mail: journal@endocrinology.or.kr                

Copyright © 2021 by Korean Endocrine Society. All rights reserved.

Developed in M2PI

Close layer
prev next
Close layer
prev next